Serum Free Light Chain Trends Between Orthotopic Heart Transplantation and Auto-SCT in Patients with AL Amyloidosis

Overview

Journal Bone Marrow Transplant

Specialty General Surgery

Date 2015 Mar 10

PMID 25751645

Authors

A S Renteria

V Sanchorawala

E D Niehaus

F Sun

M J Semigran

D C Seldin

Affiliations

Soon will be listed here.

References

Cibeira M, Sanchorawala V, Seldin D, Quillen K, Berk J, Dember L . Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011; 118(16):4346-52. PMC: 3204906. DOI: 10.1182/blood-2011-01-330738. View

Gilstrap L, Niehaus E, Malhotra R, Ton V, Watts J, Seldin D . Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis. J Heart Lung Transplant. 2013; 33(2):149-56. PMC: 3946702. DOI: 10.1016/j.healun.2013.09.004. View

Girnius S, Seldin D, Meier-Ewert H, Sloan J, Quillen K, Ruberg F . Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement. Bone Marrow Transplant. 2013; 49(3):434-9. DOI: 10.1038/bmt.2013.192. View

Wechalekar A, Schonland S, Kastritis E, Gillmore J, Dimopoulos M, Lane T . A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis. Blood. 2013; 121(17):3420-7. DOI: 10.1182/blood-2012-12-473066. View

Gillmore J, Goodman H, Lachmann H, Offer M, Wechalekar A, Joshi J . Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis. Blood. 2005; 107(3):1227-9. DOI: 10.1182/blood-2005-08-3253. View

Dey B, Chung S, Spitzer T, Zheng H, MacGillivray T, Seldin D . Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure. Transplantation. 2010; 90(8):905-11. PMC: 2964067. DOI: 10.1097/TP.0b013e3181f10edb. View

Varr B, Liedtke M, Arai S, Lafayette R, Schrier S, Witteles R . Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies. J Heart Lung Transplant. 2011; 31(3):325-31. DOI: 10.1016/j.healun.2011.09.010. View

Lacy M, Dispenzieri A, Hayman S, Kumar S, Kyle R, Rajkumar S . Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy. J Heart Lung Transplant. 2008; 27(8):823-9. DOI: 10.1016/j.healun.2008.05.016. View

Hosenpud J, DeMarco T, Frazier O, Griffith B, Uretsky B, Menkis A . Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey. Circulation. 1991; 84(5 Suppl):III338-43. View

10.

Dispenzieri A, Gertz M, Kyle R, Lacy M, Burritt M, Therneau T . Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol. 2004; 22(18):3751-7. DOI: 10.1200/JCO.2004.03.029. View